On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...
Kennedy Jr., Trump's pick for HHS secretary. However, it remains unclear how much could actually change if Kennedy were to be ...
News-Medical speaks with Jordi Labs’ about its recent achievements, alignment with FDA expectations, and strategic ...
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...